New AGA clinical practice guidelines highlight the role of noninvasive biomarkers, including fecal calprotectin, fecal lactoferrin and C-reactive protein, for the management of patients with ...

FC, Calprotectin; FL, Lactoferrin; MPO, Myeloperoxidase; CRP, C-reactive-protein; ESR, Erythrocyte sedimentation rate; ST2, Suppression of tumorigenicity 2, TNFAIP6 ...

Some ulcerative colitis patients may not need to be monitored as often with invasive endoscopies, according to new guidelines from the American Gastroenterological Association (AGA). Published this ...

Bethesda, MD (Feb. 21, 2023) — In new evidence-based guidelines, the American Gastroenterological Association (AGA) recommends non-invasive biomarkers as a first-line strategy for monitoring many ...

The global burden of inflammatory bowel diseases (IBD), primarily Crohn's disease (CD) and ulcerative colitis (UC), continues to rise. Recent data show incidence rates of up to 17.8 cases per 100,000 ...

In new evidence-based guidelines, the American Gastroenterological Association (AGA) recommends non-invasive biomarkers as a first-line strategy for monitoring many patients with ulcerative colitis ...

Lactoferrin is an iron‐binding glycoprotein fundamental to the mammalian innate immune system. Widely distributed in milk, bodily fluids and secretions, this multifunctional protein not only ...

Immune-mediated diarrhea and colitis (IMDC) is among the most common immune-related adverse events in patients with cancer treated with immune checkpoint inhibitors (ICIs). Many factors will affect ...